Skip to main content

Table 3 Clinical and demographic factors analyzed for the association with MSI-H cancer (n = 1000)

From: Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses

 

n

MSI positive

Univariate analysis

Multivariate analysis

n

%

Odd’s ratio (95% confidence interval)

P value

Odd’s ratio (95% confidence interval)

P value

Age

  ≤ 50y.o.

179

27

15.1%

1.88 (1.17–3.01)

0.01

  

  > 50y.o

821

71

8.6%

    

Gender

 Male

519

42

8.1%

0.67 (0.44–1.02)

0.07

  

 Female

481

56

11.6%

    

HBsAg and HCVAb

 Both (−)

950

92

9.7%

0.72 (0.26–2.02)

0.54

  

 Either (+)

31

4

12.9%

    

Smoker

 Yes

576

58

10.1%

1.10 (0.71–1.64)

0.83

  

 No

424

40

9.4%

    

Drinker

 Yes

486

43

8.8%

0.81 (0.53–1.23)

0.34

  

 No

514

55

10.7%

    

Cancer type

 LS(AII)-related cancers§

556

87

15.6%

7.30 (3.88–13.72)

< 0.0001

9.56 (4.09–28.05)

< 0.0001

 Others

444

11

2.5%

    

 LS(rB)-related cancers#

844

92

10.9%

3.06 (1.34–6.95)

0.005

  

 Others

156

6

3.8%

    

Purpose of MSI test

 Genetic counseling

222

74

33.3%

15.71 (9.63–25.62)

< 0.0001

15.01 (8.91–26.17)

< 0.0001

 Companion diagnostics

778

24

3.1%

    
  1. MSI-H high frequency of microsatellite instability, AII Amsterdam II criteria, rB revised Bethesda guidelines.LS(AII)-related cancers consist of colorectal cancer, endometrial cancer, renal pelvic and ureteral cancers, and small intestine cancer, and LS(rB)-related cancers include additional tumors; gastric cancer, ovarian cancer, pancreatic cancer, biliary tract cancer, brain tumor, and two cutaneous neoplasms (sebaceous adenoma and keratoacanthoma)